BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohammed A, F K Alghetaa H, Miranda K, Wilson K, P Singh N, Cai G, Putluri N, Nagarkatti P, Nagarkatti M. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression. Int J Mol Sci 2020;21:E6244. [PMID: 32872332 DOI: 10.3390/ijms21176244] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Ucar A, Parlak V, Ozgeris FB, Yeltekin AC, Arslan ME, Alak G, Turkez H, Kocaman EM, Atamanalp M. Magnetic nanoparticles-induced neurotoxicity and oxidative stress in brain of rainbow trout: Mitigation by ulexite through modulation of antioxidant, anti-inflammatory, and antiapoptotic activities. Sci Total Environ 2022;838:155718. [PMID: 35525350 DOI: 10.1016/j.scitotenv.2022.155718] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Park Y, Na H, Kwon I, Hwang Y, Park H, Kwon T, Park J, Kim K. Cannabidiol Regulates PPARγ-Dependent Vesicle Formation as well as Cell Death in A549 Human Lung Cancer Cells. Pharmaceuticals 2022;15:836. [DOI: 10.3390/ph15070836] [Reference Citation Analysis]
3 McGrail J, Martín-Banderas L, Durán-Lobato M. Cannabinoids as Emergent Therapy Against COVID-19. Cannabis Cannabinoid Res 2022. [PMID: 35512732 DOI: 10.1089/can.2022.0018] [Reference Citation Analysis]
4 Suryavanshi SV, Zaiachuk M, Pryimak N, Kovalchuk I, Kovalchuk O. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro. Cells 2022;11:1391. [DOI: 10.3390/cells11091391] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ashtar Nakhaei N, Najarian A, Farzaei MH, Norooznezhad AH. Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story? J Cannabis Res 2022;4. [DOI: 10.1186/s42238-022-00129-w] [Reference Citation Analysis]
6 Janecki M, Graczyk M, Lewandowska AA, Pawlak Ł. Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection. IJMS 2022;23:4170. [DOI: 10.3390/ijms23084170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Alharris E, Mohammed A, Alghetaa H, Zhou J, Nagarkatti M, Nagarkatti P. The Ability of Resveratrol to Attenuate Ovalbumin-Mediated Allergic Asthma Is Associated With Changes in Microbiota Involving the Gut-Lung Axis, Enhanced Barrier Function and Decreased Inflammation in the Lungs. Front Immunol 2022;13:805770. [DOI: 10.3389/fimmu.2022.805770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sultan M, Wilson K, Abdulla OA, Busbee PB, Hall A, Carter T, Singh N, Chatterjee S, Nagarkatti P, Nagarkatti M. Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis. Cells 2021;10:3305. [PMID: 34943813 DOI: 10.3390/cells10123305] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Kicman A, Pędzińska-Betiuk A, Kozłowska H. The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases. Eur J Pharmacol 2021;911:174560. [PMID: 34648805 DOI: 10.1016/j.ejphar.2021.174560] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
10 Dopkins N, Miranda K, Wilson K, Holloman BL, Nagarkatti P, Nagarkatti M. Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol 2021. [PMID: 34757526 DOI: 10.1007/s11481-021-10023-6] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Deng W, Zeng J, Lu S, Li C. Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome. IET Syst Biol 2021. [PMID: 34350693 DOI: 10.1049/syb2.12034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Graczyk M, Lewandowska AA, Dzierżanowski T. The Therapeutic Potential of Cannabis in Counteracting Oxidative Stress and Inflammation. Molecules 2021;26:4551. [PMID: 34361704 DOI: 10.3390/molecules26154551] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
13 Holloman BL, Nagarkatti M, Nagarkatti P. Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases. Int J Mol Sci 2021;22:7302. [PMID: 34298921 DOI: 10.3390/ijms22147302] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Bhatt HK, Song D, Musgrave G, Rao PSS. Cannabinoid-induced changes in the immune system: The role of microRNAs. Int Immunopharmacol 2021;98:107832. [PMID: 34107381 DOI: 10.1016/j.intimp.2021.107832] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Jha NK, Sharma C, Hashiesh HM, Arunachalam S, Meeran MN, Javed H, Patil CR, Goyal SN, Ojha S. β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Front Pharmacol 2021;12:590201. [PMID: 34054510 DOI: 10.3389/fphar.2021.590201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nigro E, Formato M, Crescente G, Daniele A. Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds? Molecules 2021;26:2668. [PMID: 34063214 DOI: 10.3390/molecules26092668] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
17 Sultan M, Alghetaa H, Mohammed A, Abdulla OA, Wisniewski PJ, Singh N, Nagarkatti P, Nagarkatti M. The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways. Front Pharmacol 2021;12:644281. [PMID: 33995054 DOI: 10.3389/fphar.2021.644281] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
18 Aghayari Sheikh Neshin S, Shahjouei S, Koza E, Friedenberg I, Khodadadi F, Sabra M, Kobeissy F, Ansari S, Tsivgoulis G, Li J, Abedi V, Wolk DM, Zand R. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology. Front Cardiovasc Med 2021;8:649922. [PMID: 33855053 DOI: 10.3389/fcvm.2021.649922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Silmore LH, Willmer AR, Capparelli EV, Rosania GR. Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies. Pharmacotherapy 2021;41:405-20. [PMID: 33583102 DOI: 10.1002/phar.2512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
20 Alghetaa H, Mohammed A, Zhou J, Singh N, Nagarkatti M, Nagarkatti P. Resveratrol-mediated attenuation of superantigen-driven acute respiratory distress syndrome is mediated by microbiota in the lungs and gut. Pharmacol Res 2021;167:105548. [PMID: 33722710 DOI: 10.1016/j.phrs.2021.105548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
21 Kaminski NE, Kaplan BLF. Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic application. Adv Pharmacol 2021;91:1-59. [PMID: 34099105 DOI: 10.1016/bs.apha.2021.01.001] [Reference Citation Analysis]
22 Nagarkatti P, Miranda K, Nagarkatti M. Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019. Front Pharmacol 2020;11:589438. [PMID: 33240092 DOI: 10.3389/fphar.2020.589438] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
23 Palit P, Chattopadhyay D, Thomas S, Kundu A, Kim HS, Rezaei N. Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19? Phytomedicine 2021;85:153396. [PMID: 33380375 DOI: 10.1016/j.phymed.2020.153396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]